CN1076115A - A kind of new drug for the treatment of tuberculosis fistula and skin infection - Google Patents
A kind of new drug for the treatment of tuberculosis fistula and skin infection Download PDFInfo
- Publication number
- CN1076115A CN1076115A CN93110015A CN93110015A CN1076115A CN 1076115 A CN1076115 A CN 1076115A CN 93110015 A CN93110015 A CN 93110015A CN 93110015 A CN93110015 A CN 93110015A CN 1076115 A CN1076115 A CN 1076115A
- Authority
- CN
- China
- Prior art keywords
- milliliters
- oil
- caretta
- sanguis
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
A kind of new drug for the treatment of tuberculosis fistula and skin infection is characterized in that: it comprises water preparation and oil preparation, and water preparation is made up of Sanguis cervi, Sanguis caretta caretta and eagle blood, and each component volume percent is: Sanguis cervi 86-94, Sanguis caretta caretta 3-7, eagle blood 3-7; Oil preparation is made up of wolf oil and Oviductus Ranae, and its volume percent is: wolf oil 30-60, Oviductus Ranae 40-70.Advantage of the present invention is: water preparation can play antibacterial, convergence, suppress the effect ooze out; can remove simultaneously the slough of wound surface; and oil preparation can suppress the tulase growth; impel tissue newborn, protect fresh granulation, cambium is without prejudice; so can make focus obtain repairing; disorganize obtains preventing, and makes the rapid locking of fistula, reaches the purpose of healing.
Description
The present invention relates to a kind of new drug for the treatment of tuberculosis fistula and skin infection.
The tuberculosis fistula is exactly a kind of obstinate disease since ancient times.Fistula is not healed, suppurates more than all the year round, and patient health is had a strong impact on, and causes the misery of the spirit and the human body and heavy financial burden.
At present nitrofural, ethacridine and intramuscular injection streptomycin and oral anti-tuberculous drug etc. are generally adopted in the treatment of tuberculosis fistula and skin infection.Said medicine does not have specific action to tuberculosis fistula and skin infection, can only play the effect of drain, even not thorough, can not be at the pathological characteristic of tuberculosis fistula, the people fundamentally treats granuloma, can not eliminate the tuberculosis pus, thereby slough produces constantly, make tuberculosis fistula obstinate, patient's body constitution go fromes bad to worse under long-term consumption, chronic consumption body constitution, low albumen occur, be unfavorable for that more wound is compound, produce serious vicious cycle.
The medicine that the purpose of this invention is to provide a kind of novel therapeutic tuberculosis fistula and skin infection, it can overcome existing shortcoming in the prior art.
The object of the present invention is achieved like this: it comprises water preparation and oil preparation, and water preparation is made up of Sanguis cervi, Sanguis caretta caretta and eagle blood, and the each component volume percent is: Sanguis cervi 86-94, Sanguis caretta caretta 3-7, eagle blood 3-7; Oil preparation is made up of wolf oil and Chinese forest frog oil, and its volume percent is: wolf oil 30-60, Chinese forest frog oil 40-70.
During use, at first meche is picked water preparation and be applied to wound surface, pick oil preparation with gauze then and smear wound surface.
That water preparation of the present invention mainly plays a part is antibacterial, convergence, suppress to ooze out; can remove simultaneously the slough of wound surface; and oil preparation can suppress the tulase growth; impel tissue newborn, protect fresh granulation, cambium is without prejudice; so can make focus obtain repairing; disorganize obtains preventing, and makes the rapid locking of fistula, reaches the purpose of healing.Through clinical verification, use this agent meche treatment, three days to can eliminating scrofulous gumma, slough and tuberculosis pus a week, and 40 days to 50 days tuberculosis fistulas and skin infection can be closed, reach clinical cure.
Below be specific embodiments of the invention:
One, in per 1000 milliliters of water preparations, contain:
940 milliliters of Sanguis cervi, 30 milliliters of eagle blood, 30 milliliters of Sanguis caretta caretta;
In per 1000 milliliters of oil preparationes, contain:
450 milliliters of wolf oil, 550 milliliters of Chinese forest frog oils.
Two, in per 1000 milliliters of water preparations, contain:
860 milliliters of Sanguis cervi, 70 milliliters of eagle blood, 70 milliliters of Sanguis caretta caretta;
In per 1000 milliliters of oil preparationes, contain:
300 milliliters of wolf oil, 700 milliliters of Chinese forest frog oils.
Three, in per 1000 milliliters of water preparations, contain:
900 milliliters of Sanguis cervi, 40 milliliters of eagle blood, 60 milliliters of Sanguis caretta caretta;
In per 1000 milliliters of oil preparationes, contain:
600 milliliters of wolf oil, 400 milliliters of Chinese forest frog oils.
Claims (4)
1, a kind of new drug for the treatment of tuberculosis fistula and skin infection, it is characterized in that: it comprises water preparation and oil preparation, and water preparation is made up of Sanguis cervi, Sanguis caretta caretta and eagle blood, and the each component volume percent is: Sanguis cervi 86-94, Sanguis caretta caretta 3-7, eagle blood 3-7; Oil preparation is made up of wolf oil and Chinese forest frog oil, and its volume percent is: wolf oil 30-60, Chinese forest frog oil 40-70.
2, a kind of new drug for the treatment of tuberculosis fistula and skin infection according to claim 1 is characterized in that: contain in per 1000 milliliters of water preparations:
940 milliliters of Sanguis cervi, 30 milliliters of eagle blood, 30 milliliters of Sanguis caretta caretta;
In per 1000 milliliters of oil preparationes, contain:
450 milliliters of wolf oil, 550 milliliters of Chinese forest frog oils.
3, a kind of new drug for the treatment of tuberculosis fistula and skin infection according to claim 1 is characterized in that: contain in per 1000 milliliters of water preparations:
860 milliliters of Sanguis cervi, 70 milliliters of eagle blood, 70 milliliters of Sanguis caretta caretta;
In per 1000 milliliters of oil preparationes, contain:
300 milliliters of wolf oil, 700 milliliters of Chinese forest frog oils.
4, a kind of new drug for the treatment of tuberculosis fistula and skin infection according to claim 1 is characterized in that: contain in per 1000 milliliters of water preparations:
900 milliliters of Sanguis cervi, 40 milliliters of eagle blood, 60 milliliters of Sanguis caretta caretta;
In per 1000 milliliters of oil preparationes, contain:
600 milliliters of wolf oil, 400 milliliters of Chinese forest frog oils.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN93110015A CN1076115A (en) | 1993-01-08 | 1993-01-08 | A kind of new drug for the treatment of tuberculosis fistula and skin infection |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN93110015A CN1076115A (en) | 1993-01-08 | 1993-01-08 | A kind of new drug for the treatment of tuberculosis fistula and skin infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1076115A true CN1076115A (en) | 1993-09-15 |
Family
ID=4987925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN93110015A Pending CN1076115A (en) | 1993-01-08 | 1993-01-08 | A kind of new drug for the treatment of tuberculosis fistula and skin infection |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1076115A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010073348A (en) * | 2000-01-14 | 2001-08-01 | 김종옥 | Processing methods of health food using soft-shell turtle, deer and crude drugs |
| US9620269B2 (en) | 2014-05-11 | 2017-04-11 | Shenyang General Magnetic Co., Ltd | Method and equipment for processing NdFeB rare earth permanent magnetic alloy with hydrogen pulverization |
-
1993
- 1993-01-08 CN CN93110015A patent/CN1076115A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010073348A (en) * | 2000-01-14 | 2001-08-01 | 김종옥 | Processing methods of health food using soft-shell turtle, deer and crude drugs |
| US9620269B2 (en) | 2014-05-11 | 2017-04-11 | Shenyang General Magnetic Co., Ltd | Method and equipment for processing NdFeB rare earth permanent magnetic alloy with hydrogen pulverization |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1265822C (en) | Medicine for treating superficial and deep burn and scald | |
| CN1049142C (en) | Qufushengjisan powder medicine capable of removing putrid tissues and promoting growth of new tissues and shengjisan powder | |
| CN1076115A (en) | A kind of new drug for the treatment of tuberculosis fistula and skin infection | |
| CN1562106A (en) | Paste for treating shank ulcer and bedsore | |
| CN100393332C (en) | Tissue regenerating ointment with repercussive and toxin-draining functions | |
| CN1209147C (en) | Medicinal power for treating external trauma | |
| RU2599126C2 (en) | Method of treatment skin wounds in mammals with the help of thrombocytic auto plasma | |
| CN1098097C (en) | External-use ointment for treating burns and scalds | |
| CN112704691B (en) | Traditional Chinese medicine ointment for promoting wound healing and reducing scar formation and preparation method thereof | |
| CN1232282C (en) | Tincture for pain-relieving, inflammation-fdiminishing, decay-eliminating and tissue regeneration and preparing method thereof | |
| CN1038643C (en) | Preparation method of injection for treating hircus | |
| CN1294915C (en) | Eliminating stasis and tissue generation toxic removing pill | |
| CN1163254C (en) | Medicine for treating burn | |
| CN1151804C (en) | Medicine for treating acne and traumatic injury | |
| CN1899350A (en) | Chinese medicine for preventing subcutaneous hemorrhage after pulling out needle | |
| CN1141967C (en) | Externally applied Chinese medicine oil prepn for treating burns and scalds | |
| CN1117855A (en) | Injection for treating haemorrhoids and fistulae and production method thereof | |
| CN105288294A (en) | Traditional Chinese medicine composition for emergency trauma bleeding | |
| CN117482176A (en) | Wound repair traditional Chinese medicine composition for healing without scar, and preparation method and application thereof | |
| CN1160086C (en) | Yatong Yicijing medicine for curing toothache | |
| CN1099979A (en) | Suppurative wound treating medicine for domestic animal | |
| CN1085947C (en) | Powder prepared with colophony, realgar and 'Huangdan' | |
| Gopinathan et al. | Effect of Calendula officinalis in burn wounds of bovine calves and heifers | |
| CN103989772A (en) | Traditional Chinese medicament for treating skin ulcer and reducing scar formation and preparation process thereof | |
| RU2282466C2 (en) | Method for treating patients for inflammatory and pyonecrotic finger and hand diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |